Eurofarma Laboratórios S.A. Stock

Stocks

EUFA3

BREUFAACNOR4

Market Closed - Sao Paulo			5-day change	1st Jan Change
- ^BRL	-.--%		-.--%	-

08-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Latest news: Eurofarma Laboratórios S.A.

08-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
01-23	Bavarian Nordic A/S Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil	CI
12-10	Psivant Therapeutics, Inc. announced that it has received $47.5 million in funding from YK Bioventures, Samsara BioCapital LLC, Roivant Sciences Ltd., LSV Capital Management, LLC, Eurofarma Laboratórios S.A. and other investors	CI
11-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-10-21	Mentis Care, Inc Appoints Hassan Kotob as Chief Executive Officer	CI
25-10-21	SK Biopharmaceuticals Co., Ltd. Launches Joint Venture with Eurofarma for Ai-Based Epilepsy Management Platform	CI
25-08-21	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-03-16	Eurofarma Laboratórios S.A. acquired 60% stake in Klibra Agenciamento de Marcas e Negócios for approximately BRL 160 million.	CI
24-11-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

More news

Managers and Directors: Eurofarma Laboratórios S.A.

Manager	Title	Age	Since
Marco Billi CEO	Chief Executive Officer	-	2021-11-22
Alexandre Mendes Palhares IRC	Investor Relations Contact	40	2021-11-22

Director	Title	Age	Since
Maurízio Billi CHM	Chairman	-	2021-11-22
Cristina Presz Palmaka de Luca BRD	Director/Board Member	58	2021-11-22
Juliana Rozenbaum Munemori BRD	Director/Board Member	50	2018-12-31

More insiders

Latest insider transactions

Date	Insider	Type	Quantity	% Market Cap.
1/10/25	Controlling Shareholder Brazilian	Buy	1,644,236	0.1665%
12/4/24	Controlling Shareholder Brazilian	Sell	15,405,639	1.5600%
12/4/24	Controlling Shareholder Brazilian	Buy	15,405,639	1.5600%

Transaction History

Financials

	2024	2025
Net sales	10.97B 2.02B 1.81B 1.66B 1.51B 2.82B 192B 2.87B 19.85B 7.97B 101B 7.58B 7.42B 318B	12.48B 2.3B 2.06B 1.89B 1.72B 3.21B 218B 3.27B 22.58B 9.06B 115B 8.62B 8.44B 362B
Net income	117M 21.6M 19.34M 17.79M 16.12M 30.14M 2.05B 30.7M 212M 85.18M 1.08B 81.06M 79.34M 3.4B	571M 105M 94.26M 86.7M 78.56M 147M 9.99B 150M 1.03B 415M 5.26B 395M 387M 16.58B
Net Debt	-	-

Projected Income Statement - Annual - Eurofarma Laboratórios S.A.

* Estimated data More financial data

Company Profile

Employees

13,000

Sector

More about the company